DK1037648T3 - Anvendelse af erythropoietin og jernpræparater til fremstilling af farmaceutiske kombinationspræparater til behandling af rheumatiske lidelser - Google Patents

Anvendelse af erythropoietin og jernpræparater til fremstilling af farmaceutiske kombinationspræparater til behandling af rheumatiske lidelser

Info

Publication number
DK1037648T3
DK1037648T3 DK98943842T DK98943842T DK1037648T3 DK 1037648 T3 DK1037648 T3 DK 1037648T3 DK 98943842 T DK98943842 T DK 98943842T DK 98943842 T DK98943842 T DK 98943842T DK 1037648 T3 DK1037648 T3 DK 1037648T3
Authority
DK
Denmark
Prior art keywords
preparation
preparations
treatment
erythropoietin
iron
Prior art date
Application number
DK98943842T
Other languages
English (en)
Inventor
Paul Lehmann
Joachim Peter Kaltwasser
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of DK1037648T3 publication Critical patent/DK1037648T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK98943842T 1997-08-08 1998-08-05 Anvendelse af erythropoietin og jernpræparater til fremstilling af farmaceutiske kombinationspræparater til behandling af rheumatiske lidelser DK1037648T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19734293A DE19734293A1 (de) 1997-08-08 1997-08-08 Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
PCT/EP1998/004864 WO1999007401A2 (de) 1997-08-08 1998-08-05 Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen

Publications (1)

Publication Number Publication Date
DK1037648T3 true DK1037648T3 (da) 2004-08-02

Family

ID=7838328

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98943842T DK1037648T3 (da) 1997-08-08 1998-08-05 Anvendelse af erythropoietin og jernpræparater til fremstilling af farmaceutiske kombinationspræparater til behandling af rheumatiske lidelser

Country Status (15)

Country Link
US (1) US6372715B1 (da)
EP (1) EP1037648B1 (da)
JP (3) JP2001513510A (da)
KR (1) KR100478573B1 (da)
CN (1) CN1170589C (da)
AT (1) ATE263571T1 (da)
AU (1) AU738027B2 (da)
BR (1) BR9811086A (da)
CA (1) CA2297959C (da)
DE (2) DE19734293A1 (da)
DK (1) DK1037648T3 (da)
ES (1) ES2218851T3 (da)
PT (1) PT1037648E (da)
TR (1) TR200000369T2 (da)
WO (1) WO1999007401A2 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0977582T3 (da) * 1997-03-18 2002-12-16 Roche Diagnostics Gmbh Farmaceutiske kombinationspræparater, der indeholder erythropoietin og jernpræparater
DE19734293A1 (de) * 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
HU230874B1 (hu) * 2000-05-15 2018-11-29 F. Hoffmann-La Roche Ag Pegilezett humán eritropoietin-fehérjét tartalmazó, szobahőmérsékleten stabil folyékony gyógyászati készítmények
US6929954B2 (en) * 2000-11-02 2005-08-16 Chromaceutical Advanced Technologies, Inc. Method for producing purified hematinic iron-saccharidic complex and product produced
WO2002056826A2 (en) * 2000-11-02 2002-07-25 Chromaceutical Advanced Technologies, Inc. Method for producing purified hematinic iron-saccharidic complex and product produced
AU3323002A (en) 2000-12-20 2002-07-01 Hoffmann La Roche Erythropoietin conjugates
EP1909106B1 (en) 2001-09-14 2013-01-02 F. Hoffmann-La Roche AG Differential diagnosis of disorders of iron metabolism by means of four parameters and recommendations for the treatment of these disorders of iron metabolism
US7459435B2 (en) * 2002-08-29 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7459436B2 (en) * 2002-11-22 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7964568B2 (en) * 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
CN101155593A (zh) * 2005-02-09 2008-04-02 维福（国际）股份公司 铁（ⅲ）络合物化合物的应用
CA2898009C (en) * 2005-05-16 2018-03-27 Rebecca S. Hoffman Use of tnfa inhibitor for treatment of erosive polyarthritis
EP1790356A1 (de) * 2005-11-24 2007-05-30 Vifor (International) Ag Präparat, umfassend Eisen(III)-Komplexverbindungen und redoxaktive Substanz(en)
US9605064B2 (en) 2006-04-10 2017-03-28 Abbvie Biotechnology Ltd Methods and compositions for treatment of skin disorders
US9399061B2 (en) * 2006-04-10 2016-07-26 Abbvie Biotechnology Ltd Methods for determining efficacy of TNF-α inhibitors for treatment of rheumatoid arthritis
US20080131374A1 (en) * 2006-04-19 2008-06-05 Medich John R Uses and compositions for treatment of rheumatoid arthritis
CA2659990C (en) 2006-08-04 2016-03-22 Prolong Pharmaceuticals, Inc. Polyethylene glycol erythropoietin conjugates
US20080132465A1 (en) * 2006-12-05 2008-06-05 Vincent Windisch Apparatus and method for isolating iron components from serum
CL2008002053A1 (es) * 2007-07-17 2009-05-22 Hoffmann La Roche Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion.
CL2008002054A1 (es) * 2007-07-17 2009-05-29 Hoffmann La Roche Metodo para la regeneracion de una columna de cromatografia de intercambio cationico despues de la elusion de eritropoyetina monopeguilada y metodo para obtener una eritropoyetina monopeguilada, incorporando el metodo de regeneracion de la columna de intercambio cationico.
CN102282173A (zh) * 2008-03-24 2011-12-14 艾博特生物技术有限公司 用于治疗骨丢失的方法和组合物
US8202830B2 (en) 2009-01-30 2012-06-19 Ecolab Usa Inc. Development of an aluminum hydroxydicarboxylate builder
BRPI1006847B1 (pt) * 2009-01-30 2019-11-26 Ecolab Inc composição de limpeza para remover sujeiras, composição detergente e método de remoção de sujeiras
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
JP6085401B2 (ja) * 2014-07-25 2017-02-22 原　和弘 薬剤投与情報提供装置及び薬剤投与情報提供のためのコンピュータプログラム
DK3380487T3 (da) 2015-11-23 2020-12-07 Bristol Myers Squibb Co Additivsystemer til anvendelse i proteinpegylering

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ194947A (en) * 1979-09-18 1983-06-14 C Holland Composition containing calcium and ferrous ions for treatment of rheumatoid arthritis
US4732889A (en) * 1985-02-06 1988-03-22 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of rheumatoid arthritis
EP0784480B1 (en) * 1994-11-03 2003-10-15 Boehringer Mannheim Gmbh Use of erythropoietin in the treatment of rheumatoid arthritis
DE19535571A1 (de) * 1995-09-14 1997-03-20 Boehringer Mannheim Gmbh Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
DE19734293A1 (de) * 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen

Also Published As

Publication number Publication date
JP2012012410A (ja) 2012-01-19
JP2008133290A (ja) 2008-06-12
EP1037648B1 (de) 2004-04-07
AU738027B2 (en) 2001-09-06
JP2001513510A (ja) 2001-09-04
WO1999007401A2 (de) 1999-02-18
ATE263571T1 (de) 2004-04-15
US6372715B1 (en) 2002-04-16
TR200000369T2 (tr) 2000-09-21
PT1037648E (pt) 2004-08-31
KR100478573B1 (ko) 2005-03-28
DE59811158D1 (de) 2004-05-13
CA2297959C (en) 2011-11-29
CA2297959A1 (en) 1999-02-18
DE19734293A1 (de) 1999-02-11
KR20010022738A (ko) 2001-03-26
CN1170589C (zh) 2004-10-13
EP1037648A2 (de) 2000-09-27
CN1268058A (zh) 2000-09-27
ES2218851T3 (es) 2004-11-16
AU9159098A (en) 1999-03-01
WO1999007401A3 (de) 1999-04-29
BR9811086A (pt) 2000-08-29

Similar Documents

Publication Publication Date Title
DK1037648T3 (da) Anvendelse af erythropoietin og jernpræparater til fremstilling af farmaceutiske kombinationspræparater til behandling af rheumatiske lidelser
HRP20020088B1 (en) Levodopa/carbidopa/entacapone pharmaceutical preparation
TR200002207T1 (tr) Slekoksib bileşikleri.
SE9703191D0 (sv) Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
IS5500A (is) Lyfjablöndur til öftrunar og meðferðar mýlildi ogtengdum sjúkdómum
SE9704869D0 (sv) New pharmaceutical formulaton II
AR032293A1 (es) Estuche farmaceutico
HK1068606A1 (en) Novel aminobenzoephenones
IS7006A (is) Tvívetnis 3-piperidínóprópíófenon og lyf sem innihalda téð efnasambönd
GR1002847B (el) Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως
HUP0104647A2 (hu) Hatóanyagként tilidin-mezilátot tartalmazó, szabályozott hatóanyag-leadású gyógyszerkészítmény
PT998287E (pt) Utilizacao de levobupivacaina
HUP9700806A2 (hu) Tianeptin-nátriumsó nyújtott felszabadulását biztosító, szájon át beadható mátrix tabletta és eljárás előállítására
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
SE8901003D0 (sv) Snabbloesliga preparat
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine
PT900563E (pt) Producao de formulacoes farmaceuticas para o tratamento de edema e doencas venosas
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
HUP9901659A2 (hu) Flupirtin alkalmazása a hematopoetikus sejtrendszer károsodásával kapcsolatos megbetegedések megelőzésére és gyógyítására alkalmas gyógyszerkészítmény előállítására
HUP0200145A2 (hu) Tianeptin alkalmazása neurodegeneratív betegségek kezelésére alkalmas gyógyszerkészítmények előállítására
TR199700963T1 (xx) Kardiyovask�ler hastal�klar�n tedavisi i�in aminotetralin t�revi.
IT8026233A0 (it) Derivato della n-acetil-cisteina ad attivita' terapeutica, procedimento per la sua preparazione e relative composizioni farmaceutiche.
PT1231908E (pt) Composicao farmaceutica compreendendo um composto dador de no e sua utilizacao em terapia